Arch Virol

1. SEDOHARA A, Takahashi K, Arai K, Arizono K, et al
   Characterization of mutations in hepatitis B virus DNA isolated from Japanese HBsAg-positive blood donors in 2021 and 2022.
   Arch Virol. 2024;169:103.
   

   >> Share

   
   

   
   BMC Cancer

2. HAO X, Xu L, Lan X, Li B, et al
   Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after hepatectomy.
   BMC Cancer. 2024;24:475.
   

   >> Share

   
   

   
   BMC Gastroenterol

3. KRANIDIOTI H, Zisimopoulos K, Oikonomou T, Voulgaris T, et al
   Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study.
   BMC Gastroenterol. 2024;24:133.
   

   >> Share

   
   

   
   Clin Infect Dis

4. HOOD RB, Norris AH, Shoben A, Miller WC, et al
   Forecasting Hepatitis C Virus Status for Children in the United States: A Modeling Study.
   Clin Infect Dis. 2024 Apr 17:ciae157. doi: 10.1093.
   

   >> Share

   
   

   
   Gut

5. THORNTON CS, Waddell BJ, Congly SE, Svishchuk J, et al
   Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients.
   Gut. 2024 Apr 15:gutjnl-2023-330602. doi: 10.1136/gutjnl-2023-330602.
   

   >> Share

   
   

   
   Hepatology

6. ZAHOOR MA, Feld JB, Lin HS, Mosa AI, et al
   Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN trials.
   Hepatology. 2024 Apr 17. doi: 10.1097/HEP.0000000000000878.
   

   >> Share

   
   
7. SHENOY A, Fontana RJ
   HDV screening in chronic HBV: An unmet need of growing importance.
   Hepatology. 2024;79:979-982.
   

   >> Share

   
   

   
   J Infect Dis

8. BEGRE L, Boyd A, Plissonnier ML, Testoni B, et al
   Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
   J Infect Dis. 2024 Apr 16:jiae189. doi: 10.1093.
   

   >> Share

   
   
9. SCHMIDT S, Mengistu M, Daffis S, Ahmadi-Erber S, et al
   Alternating Arenavirus Vector Immunization Generates Robust Polyfunctional Genotype Cross-Reactive Hepatitis B Virus-Specific CD8 T-Cell Responses and High Anti-Hepatitis B Surface Antigen Titers.
   J Infect Dis. 2024;229:1077-1087.
   

   >> Share

   
   

   
   J Med Virol

10. CHEN L, Tao X, Zeng M, Li Y, et al
    Noninvasive tests maintain high accuracy for advanced fibrosis in chronic hepatitis B patients with different nomenclatures of steatotic liver disease.
    J Med Virol. 2024;96:e29613.
    

    >> Share

    
    
11. HOU L, Zhao J, Cai L, Jin L, et al
    HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase.
    J Med Virol. 2024;96:e29607.
    

    >> Share

    
    

    
    J Viral Hepat

12. OLTMANNS C, Bremer B, Kusche L, Stal P, et al
    Elevation of S2-bound alpha1-acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma.
    J Viral Hepat. 2024 Apr 12. doi: 10.1111/jvh.13943.
    

    >> Share

    
    
13. WONG RJ, Hirode G, Feld J, Wong SS, et al
    An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13939.
    

    >> Share

    
    
14. ALQAHTANI SA, Yilmaz Y, El-Kassas M, Alswat K, et al
    Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.
    J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935.
    

    >> Share

    
    

    
    J Virol

15. SCHOLLMEIER A, Basic M, Glitscher M, Hildt E, et al
    The impact of HBx protein on mitochondrial dynamics and associated signaling pathways strongly depends on the hepatitis B virus genotype.
    J Virol. 2024 Apr 17:e0042424. doi: 10.1128/jvi.00424.
    

    >> Share

    
    

    
    JAMA

16. VOELKER R
    What Is Hepatitis D Infection?
    JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.1317.
    

    >> Share

    
    

    
    Pediatr Infect Dis J

17. MORRIS N, Hunter K, Bhat V, Kushnir A, et al
    Hepatitis C Exposure Diagnosis and Testing in Infants Born to Hepatitis C Virus-infected Mothers.
    Pediatr Infect Dis J. 2024 Apr 10. doi: 10.1097/INF.0000000000004355.
    

    >> Share

    
    

    
    PLoS One

18. DEBSIKREO N, Mankreo BL, Moukenet A, Ouangkake M, et al
    Prevalence of hepatitis B virus infection and its associated factors among students in N'Djamena, Chad.
    PLoS One. 2024;19:e0273589.
    

    >> Share

    
    
19. TADESSE K, Ayalew G, Million Y, Gelaw A, et al
    Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.
    PLoS One. 2024;19:e0301973.
    

    >> Share

    
    
20. SENOO-DOGBEY VE, Anto F, Quansah R, Danso-Appiah A, et al
    Completion of three-dose hepatitis B vaccination cycle and associated factors among health care workers in the Greater Accra Region of Ghana.
    PLoS One. 2024;19:e0298771.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

21. PAPINI C, Ullah I, Ranjan AP, Zhang S, et al
    Proof-of-concept studies with a computationally designed M(pro) inhibitor as a synergistic combination regimen alternative to Paxlovid.
    Proc Natl Acad Sci U S A. 2024;121:e2320713121.
    

    >> Share

    
    

    
    Virology

22. TU T, Wettengel J, Xia Y, Testoni B, et al
    Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop.
    Virology. 2024;595:110089.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share